Table 1.
PD | DLB | PSP | MSA | CBD | Controls | |
---|---|---|---|---|---|---|
Total | 140 | 90 | 64 | 7 | 6 | 166 |
% Male | 67.1% | 56.7% | 64.1% | 42.9% | 50.0% | 56.0% |
age of death | 80±6.5 | 81±7.2 | 84±8.5* | 74±7.4 | 75±5.7 | 83±9.3* |
disease duration | 15±2.5┼ | 7±4.1 | 8±6.2 | 5±1.7 | 7±1.9 | n/a |
Last UPDRS | 42±20.3 | 35±26.8 | 33±19.5 | 43±28.2 | n/a*** | 8±6.8** |
months prior to death | 12±11.5 | 19±14.4 | 33±19.5 | 17±12.1 | n/a*** | 16±16.2 |
PD had significant greater disease duration when compared to DLB, PSP, CBD, and MSA cases.
PSP and control cases were significantly older than PD, CBD, and MSA cases at death.
Controls had a significantly lower average UPDRS score before death when compared to PD, DLB, PSP, and MSA.
Only one CBD case had a record of a UPDRS.